chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: her patients who did receive the vaccine were already pregnant; This spontaneous prospective pregnancy case was reported by a nurse and describes the occurrence of EXPOSURE DURING PREGNANCY (her patients who did receive the vaccine were already pregnant) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (her patients who did receive the vaccine were already pregnant). At the time of the report, EXPOSURE DURING PREGNANCY (her patients who did receive the vaccine were already pregnant) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication reported . No treatment medication reported . The nurse stated that pregnancy is not a side effect of the vaccine.  This case concerns a female patient of unknown age who experienced vaccine exposure during pregnancy after the a dose of the vaccine.  Last menstrual period and estimated date of delivery were not provided. Dechallenge is unknown and rechallenge is not applicable. The benefit-risk relationship is not affected by this report; Sender's Comments: This case concerns a female patient of unknown age who experienced vaccine exposure during pregnancy after the a dose of the vaccine.  Last menstrual period and estimated date of delivery were not provided. Dechallenge is unknown and rechallenge is not applicable. The benefit-risk relationship is not affected by this report
Age: 15.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: administered the first dose of Moderna to a 15-year-old patient; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (administered the first dose of Moderna to a 15-year-old patient) in a 15-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Jun-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (administered the first dose of Moderna to a 15-year-old patient). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (administered the first dose of Moderna to a 15-year-old patient) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant drug details were reported.  No treatment details were reported.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure abnormal, Blood pressure measurement, Chills, Dizziness, Feeling hot
Clinical narrative: blood pressure 160/50, looked terrible; Dizzy; dizzy spells lasted for 1 -2 minutes; dizzy while walking, can't walk in a straight line; 2-3 hot flashes almost every night lasting 30 seconds to 1 minute; pretty hot; shoulder and chest creating perspiration; occasionally having a chill; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE ABNORMAL (blood pressure 160/50, looked terrible), DIZZINESS (Dizzy), VERTIGO (dizzy spells lasted for 1 -2 minutes), GAIT DISTURBANCE (dizzy while walking, can't walk in a straight line) and HOT FLUSH (2-3 hot flashes almost every night lasting 30 seconds to 1 minute) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025C21A and 003C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Blood pressure low. Concomitant products included LOSARTAN for Blood pressure.   On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BLOOD PRESSURE ABNORMAL (blood pressure 160/50, looked terrible), DIZZINESS (Dizzy), VERTIGO (dizzy spells lasted for 1 -2 minutes), GAIT DISTURBANCE (dizzy while walking, can't walk in a straight line), HOT FLUSH (2-3 hot flashes almost every night lasting 30 seconds to 1 minute), FEELING HOT (pretty hot), HYPERHIDROSIS (shoulder and chest creating perspiration) and CHILLS (occasionally having a chill). At the time of the report, BLOOD PRESSURE ABNORMAL (blood pressure 160/50, looked terrible), DIZZINESS (Dizzy), VERTIGO (dizzy spells lasted for 1 -2 minutes), GAIT DISTURBANCE (dizzy while walking, can't walk in a straight line), HOT FLUSH (2-3 hot flashes almost every night lasting 30 seconds to 1 minute), FEELING HOT (pretty hot), HYPERHIDROSIS (shoulder and chest creating perspiration) and CHILLS (occasionally having a chill) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 160/50 mmHg (Low) 160/50.         Patient has not taken any medication as treatment.  Patient takes losartan for his blood pressure once a day or every 2-3 days.  Patient reported that 2 to 3 days after the second dose, he was scheduled to continue his therapy on his lower spine and had 3 sessions left to go.   Reporter did not allow further contact
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Gait disturbance, Hot flush, Hyperhidrosis, Vertigo
Clinical narrative: blood pressure 160/50, looked terrible; Dizzy; dizzy spells lasted for 1 -2 minutes; dizzy while walking, can't walk in a straight line; 2-3 hot flashes almost every night lasting 30 seconds to 1 minute; pretty hot; shoulder and chest creating perspiration; occasionally having a chill; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE ABNORMAL (blood pressure 160/50, looked terrible), DIZZINESS (Dizzy), VERTIGO (dizzy spells lasted for 1 -2 minutes), GAIT DISTURBANCE (dizzy while walking, can't walk in a straight line) and HOT FLUSH (2-3 hot flashes almost every night lasting 30 seconds to 1 minute) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025C21A and 003C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Blood pressure low. Concomitant products included LOSARTAN for Blood pressure.   On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BLOOD PRESSURE ABNORMAL (blood pressure 160/50, looked terrible), DIZZINESS (Dizzy), VERTIGO (dizzy spells lasted for 1 -2 minutes), GAIT DISTURBANCE (dizzy while walking, can't walk in a straight line), HOT FLUSH (2-3 hot flashes almost every night lasting 30 seconds to 1 minute), FEELING HOT (pretty hot), HYPERHIDROSIS (shoulder and chest creating perspiration) and CHILLS (occasionally having a chill). At the time of the report, BLOOD PRESSURE ABNORMAL (blood pressure 160/50, looked terrible), DIZZINESS (Dizzy), VERTIGO (dizzy spells lasted for 1 -2 minutes), GAIT DISTURBANCE (dizzy while walking, can't walk in a straight line), HOT FLUSH (2-3 hot flashes almost every night lasting 30 seconds to 1 minute), FEELING HOT (pretty hot), HYPERHIDROSIS (shoulder and chest creating perspiration) and CHILLS (occasionally having a chill) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 160/50 mmHg (Low) 160/50.         Patient has not taken any medication as treatment.  Patient takes losartan for his blood pressure once a day or every 2-3 days.  Patient reported that 2 to 3 days after the second dose, he was scheduled to continue his therapy on his lower spine and had 3 sessions left to go.   Reporter did not allow further contact
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Did not yet received her second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Did not yet received her second dose) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 088D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Sep-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Did not yet received her second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Did not yet received her second dose) had resolved.            No concomitant drug information was provided by reporter.  No treatment drug information was provided by reporter
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Nasal congestion, Nasopharyngitis, Rhinorrhoea, Sinus congestion
Clinical narrative: Head cold; Stuffy nose; Sneezing; Runny nose; Sinus congestion; Occasional cough; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Head cold), NASAL CONGESTION (Stuffy nose), SNEEZING (Sneezing), RHINORRHOEA (Runny nose) and SINUS CONGESTION (Sinus congestion) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (Head cold), NASAL CONGESTION (Stuffy nose), SNEEZING (Sneezing), RHINORRHOEA (Runny nose), SINUS CONGESTION (Sinus congestion) and COUGH (Occasional cough). At the time of the report, NASOPHARYNGITIS (Head cold), NASAL CONGESTION (Stuffy nose), SNEEZING (Sneezing), RHINORRHOEA (Runny nose), SINUS CONGESTION (Sinus congestion) and COUGH (Occasional cough) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication were reported  No treatment medication were reported.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Sneezing
Clinical narrative: Head cold; Stuffy nose; Sneezing; Runny nose; Sinus congestion; Occasional cough; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Head cold), NASAL CONGESTION (Stuffy nose), SNEEZING (Sneezing), RHINORRHOEA (Runny nose) and SINUS CONGESTION (Sinus congestion) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (Head cold), NASAL CONGESTION (Stuffy nose), SNEEZING (Sneezing), RHINORRHOEA (Runny nose), SINUS CONGESTION (Sinus congestion) and COUGH (Occasional cough). At the time of the report, NASOPHARYNGITIS (Head cold), NASAL CONGESTION (Stuffy nose), SNEEZING (Sneezing), RHINORRHOEA (Runny nose), SINUS CONGESTION (Sinus congestion) and COUGH (Occasional cough) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication were reported  No treatment medication were reported.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoglycaemia, Myocardial infarction, Renal failure
Clinical narrative: massive heart attack; hypoglycemic; kidney failure; This spontaneous case was reported by a consumer and describes the occurrence of RENAL FAILURE (kidney failure), MYOCARDIAL INFARCTION (massive heart attack) and HYPOGLYCAEMIA (hypoglycemic) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced RENAL FAILURE (kidney failure) (seriousness criteria hospitalization, medically significant and life threatening) and HYPOGLYCAEMIA (hypoglycemic) (seriousness criterion hospitalization). On 22-Apr-2021, the patient experienced MYOCARDIAL INFARCTION (massive heart attack) (seriousness criteria hospitalization, medically significant and life threatening). The patient was hospitalized until 01-Apr-2021 due to HYPOGLYCAEMIA, MYOCARDIAL INFARCTION and RENAL FAILURE. At the time of the report, RENAL FAILURE (kidney failure), MYOCARDIAL INFARCTION (massive heart attack) and HYPOGLYCAEMIA (hypoglycemic) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  On 24-Mar-2021 patient had a heart surgery. Company Comment: This  case concerns a 62-year-old male patient with no details on past medical history, presented with unexpected events of Myocardial Infarction, Renal failure and Hypoglycemia , these events happened on the same day of the 1st dose of vaccination with Moderna .Patient was hospitalized and underwent heart surgery. The benefit risk relationship of  Moderna vaccine  is not affected by this report.; Sender's Comments: This  case concerns a 62-year-old male patient with no details on past medical history, presented with unexpected events of Myocardial Infarction, Renal failure and Hypoglycemia , these events happened on the same day of the 1st dose of vaccination with Moderna .Patient was hospitalized and underwent heart surgery. The benefit risk relationship of  Moderna vaccine  is not affected by this report.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: reaction to vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of VACCINATION COMPLICATION (reaction to vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (reaction to vaccine). At the time of the report, VACCINATION COMPLICATION (reaction to vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Antibody test, Influenza like illness
Clinical narrative: Developed flu like symptom (after second dose); This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Developed flu like symptom (after second dose)) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised (Patient considered immunocompromised as she receives a Pegasys injection every two weeks.). Concomitant products included PEGINTERFERON ALFA-2A (PEGASYS) for Immunocompromised, ASPIRIN [ACETYLSALICYLIC ACID], CALCIUM and PROGESTERONE for an unknown indication.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Developed flu like symptom (after second dose)). At the time of the report, INFLUENZA LIKE ILLNESS (Developed flu like symptom (after second dose)) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, Antibody test: high (High) titers were high.         No treatment information was provided by the reporter.  Patient received a full dose and not half, and patient was a classic example of someone who is small. It's been 6 months since patient received the second dose. Before receiving third dose, patient asked doctor to test again for antibody, but doctor said they didn't believe in Ab testing. Patient is considered immunocompromised as patient takes Pegasys injection every two weeks. Last time received it was on 8Sep2021.   This case was linked to MOD-2021-320389 (Patient Link).
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Cerebral disorder, Headache, Heart rate, Insomnia, Oropharyngeal pain
Clinical narrative: Blurry vision; Throat tightened; Could not sleep; Throat hurt; Shakes; brain spazzing; headaches; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (Blurry vision), THROAT TIGHTNESS (Throat tightened), INSOMNIA (Could not sleep), OROPHARYNGEAL PAIN (Throat hurt) and TREMOR (Shakes) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Migraine, Brain tumor (Benign brain tumor.) and Consciousness loss (2 concussions.).    On 10-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VISION BLURRED (Blurry vision), THROAT TIGHTNESS (Throat tightened), INSOMNIA (Could not sleep), OROPHARYNGEAL PAIN (Throat hurt), TREMOR (Shakes), CEREBRAL DISORDER (brain spazzing) and HEADACHE (headaches). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form; PARACETAMOL (TYLENOL) at a dose of 1 dosage form and ACETYLSALICYLIC ACID (BABY ASPIRIN) at a dose of 1 dosage form. At the time of the report, VISION BLURRED (Blurry vision), THROAT TIGHTNESS (Throat tightened), INSOMNIA (Could not sleep), OROPHARYNGEAL PAIN (Throat hurt), TREMOR (Shakes), CEREBRAL DISORDER (brain spazzing) and HEADACHE (headaches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: 100 (High) over 100 and is normally 65.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No  concomitant drugs provided. Other treatment drug is steroids.; Sender's Comments: This case concerns a 65 year old female with significant medial history of Concussions time two, Migraines and Benign brain tumor who experienced the unlisted events of Blurry vision, Oropharyngeal pain, Throat tightness, Tremor, Cerebral disorder and listed event of Headache. The event occurred the same day as the first dose of Moderna COVID-19 vaccine and a re-challenge has not be noted. The medical history of Brain tumor, Concussions and Migraines remain confounders. The benefit-risk relationship is not affected by this report.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Throat tightness, Tremor, Vision blurred
Clinical narrative: Blurry vision; Throat tightened; Could not sleep; Throat hurt; Shakes; brain spazzing; headaches; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (Blurry vision), THROAT TIGHTNESS (Throat tightened), INSOMNIA (Could not sleep), OROPHARYNGEAL PAIN (Throat hurt) and TREMOR (Shakes) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Migraine, Brain tumor (Benign brain tumor.) and Consciousness loss (2 concussions.).    On 10-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VISION BLURRED (Blurry vision), THROAT TIGHTNESS (Throat tightened), INSOMNIA (Could not sleep), OROPHARYNGEAL PAIN (Throat hurt), TREMOR (Shakes), CEREBRAL DISORDER (brain spazzing) and HEADACHE (headaches). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form; PARACETAMOL (TYLENOL) at a dose of 1 dosage form and ACETYLSALICYLIC ACID (BABY ASPIRIN) at a dose of 1 dosage form. At the time of the report, VISION BLURRED (Blurry vision), THROAT TIGHTNESS (Throat tightened), INSOMNIA (Could not sleep), OROPHARYNGEAL PAIN (Throat hurt), TREMOR (Shakes), CEREBRAL DISORDER (brain spazzing) and HEADACHE (headaches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: 100 (High) over 100 and is normally 65.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No  concomitant drugs provided. Other treatment drug is steroids.; Sender's Comments: This case concerns a 65 year old female with significant medial history of Concussions time two, Migraines and Benign brain tumor who experienced the unlisted events of Blurry vision, Oropharyngeal pain, Throat tightness, Tremor, Cerebral disorder and listed event of Headache. The event occurred the same day as the first dose of Moderna COVID-19 vaccine and a re-challenge has not be noted. The medical history of Brain tumor, Concussions and Migraines remain confounders. The benefit-risk relationship is not affected by this report.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Breast pain, Lymph node pain, Lymphadenopathy, Myalgia, Pain
Clinical narrative: left breast so sore; pain; she had in left arm and they were so so sore; left arm and left side of her body are so sore; the lymph nodes went crazy and they were so so sore; It's really really really tender/it sure hurt; Under the armpit it was almost as big as a golf ball,it sure hurt,now it's the size of a marble; This spontaneous case was reported by a consumer and describes the occurrence of BREAST PAIN (left breast so sore), PAIN (pain), VACCINATION SITE PAIN (she had in left arm and they were so so sore), MYALGIA (left arm and left side of her body are so sore) and LYMPHADENOPATHY (the lymph nodes went crazy and they were so so sore) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M202 and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history provided by reporter.  Concomitant products included FUROSEMIDE (LASIX M) for an unknown indication.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BREAST PAIN (left breast so sore), PAIN (pain), VACCINATION SITE PAIN (she had in left arm and they were so so sore), MYALGIA (left arm and left side of her body are so sore), LYMPHADENOPATHY (the lymph nodes went crazy and they were so so sore), LYMPH NODE PAIN (It's really really really tender/it sure hurt) and LYMPHADENOPATHY (Under the armpit it was almost as big as a golf ball,it sure hurt,now it's the size of a marble). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, BREAST PAIN (left breast so sore), PAIN (pain), VACCINATION SITE PAIN (she had in left arm and they were so so sore), MYALGIA (left arm and left side of her body are so sore), LYMPHADENOPATHY (the lymph nodes went crazy and they were so so sore), LYMPH NODE PAIN (It's really really really tender/it sure hurt) and LYMPHADENOPATHY (Under the armpit it was almost as big as a golf ball,it sure hurt,now it's the size of a marble) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication also include blood pressure medication and diabetic. Patient had mammogram and an ultrasound (Results not provided.)and it brought back the pain and everything. They thought she had a cyst under her breast but it was her lymph node. Cancer doctor told her to not wear a bra.   This case was linked to MOD-2021-022641 (Patient Link).
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: left breast so sore; pain; she had in left arm and they were so so sore; left arm and left side of her body are so sore; the lymph nodes went crazy and they were so so sore; It's really really really tender/it sure hurt; Under the armpit it was almost as big as a golf ball,it sure hurt,now it's the size of a marble; This spontaneous case was reported by a consumer and describes the occurrence of BREAST PAIN (left breast so sore), PAIN (pain), VACCINATION SITE PAIN (she had in left arm and they were so so sore), MYALGIA (left arm and left side of her body are so sore) and LYMPHADENOPATHY (the lymph nodes went crazy and they were so so sore) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M202 and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history provided by reporter.  Concomitant products included FUROSEMIDE (LASIX M) for an unknown indication.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BREAST PAIN (left breast so sore), PAIN (pain), VACCINATION SITE PAIN (she had in left arm and they were so so sore), MYALGIA (left arm and left side of her body are so sore), LYMPHADENOPATHY (the lymph nodes went crazy and they were so so sore), LYMPH NODE PAIN (It's really really really tender/it sure hurt) and LYMPHADENOPATHY (Under the armpit it was almost as big as a golf ball,it sure hurt,now it's the size of a marble). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, BREAST PAIN (left breast so sore), PAIN (pain), VACCINATION SITE PAIN (she had in left arm and they were so so sore), MYALGIA (left arm and left side of her body are so sore), LYMPHADENOPATHY (the lymph nodes went crazy and they were so so sore), LYMPH NODE PAIN (It's really really really tender/it sure hurt) and LYMPHADENOPATHY (Under the armpit it was almost as big as a golf ball,it sure hurt,now it's the size of a marble) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication also include blood pressure medication and diabetic. Patient had mammogram and an ultrasound (Results not provided.)and it brought back the pain and everything. They thought she had a cyst under her breast but it was her lymph node. Cancer doctor told her to not wear a bra.   This case was linked to MOD-2021-022641 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: has serious issues; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (has serious issues) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (has serious issues). At the time of the report, ADVERSE EVENT (has serious issues) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications provided.  No treatment medications provided.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Off label use
Clinical narrative: Got another dose of the Moderna COVID-19 vaccine although he was not immunocompromised; This spontaneous case was reported by a consumer and describes the occurrence of OFF LABEL USE (Got another dose of the Moderna COVID-19 vaccine although he was not immunocompromised) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OFF LABEL USE (Got another dose of the Moderna COVID-19 vaccine although he was not immunocompromised). At the time of the report, OFF LABEL USE (Got another dose of the Moderna COVID-19 vaccine although he was not immunocompromised) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided.   It was reported that patient was doing fine.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: I had the first shot 3 months ago- it is safe to get 2nd shot; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (I had the first shot 3 months ago- it is safe to get 2nd shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (I had the first shot 3 months ago- it is safe to get 2nd shot). At the time of the report, PRODUCT DOSE OMISSION ISSUE (I had the first shot 3 months ago- it is safe to get 2nd shot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Treatment medication was not provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity, Pyrexia
Clinical narrative: Sore arm; some fatigue in the joints; felt a feverish sensation; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), FATIGUE (some fatigue in the joints) and PYREXIA (felt a feverish sensation) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: influenza vaccine in 2017. Past adverse reactions to the above products included Adverse event with influenza vaccine.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm), FATIGUE (some fatigue in the joints) and PYREXIA (felt a feverish sensation). At the time of the report, PAIN IN EXTREMITY (Sore arm), FATIGUE (some fatigue in the joints) and PYREXIA (felt a feverish sensation) outcome was unknown.            Patient allergist/immunologist and cardiologist were very pleased my COVID vaccinations went so well.  Patient was having hereditary alpha tryptasemia genetic trait, confirmed by a Gene-by-Gene genetic test. No concomitant medications were reported. No treatment information were reported.   This case was linked to MOD-2021-318734 (Patient Link).
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Has not recieved second dose yet; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Has not recieved second dose yet) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041D21A or 091D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Has not recieved second dose yet). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Has not recieved second dose yet) had resolved.            Concomitant product use was not provided.   Treatment information was not provided.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine administered beyond 12 hours after first puncture; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered beyond 12 hours after first puncture) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 062E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered beyond 12 hours after first puncture). On 16-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered beyond 12 hours after first puncture) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The vial was punctured at 9 AM on 15-Sep-2021 and used beyond the 12 hour expiry date in room temp on 16-Sep-2021.   No concomitant medications were reported. No treatment medication was reported.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Headache, Migraine, Pain, Pain in extremity
Clinical narrative: Body aches; Migraine; Their arm felt heavy/Arm ache; Had fever of 100.2°F; Strong headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), MIGRAINE (Migraine), PAIN IN EXTREMITY (Their arm felt heavy/Arm ache), PYREXIA (Had fever of 100.2°F) and HEADACHE (Strong headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cancer in remission.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Feb-2021, the patient experienced PAIN (Body aches), MIGRAINE (Migraine), PAIN IN EXTREMITY (Their arm felt heavy/Arm ache), PYREXIA (Had fever of 100.2°F), HEADACHE (Strong headache) and CHILLS (Chills). On 22-Feb-2021, PAIN (Body aches), MIGRAINE (Migraine), PYREXIA (Had fever of 100.2°F), HEADACHE (Strong headache) and CHILLS (Chills) had resolved. On 23-Feb-2021, PAIN IN EXTREMITY (Their arm felt heavy/Arm ache) had resolved.            Concomitant product use was unknown by the reporter. Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Body aches; Migraine; Their arm felt heavy/Arm ache; Had fever of 100.2°F; Strong headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), MIGRAINE (Migraine), PAIN IN EXTREMITY (Their arm felt heavy/Arm ache), PYREXIA (Had fever of 100.2°F) and HEADACHE (Strong headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cancer in remission.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Feb-2021, the patient experienced PAIN (Body aches), MIGRAINE (Migraine), PAIN IN EXTREMITY (Their arm felt heavy/Arm ache), PYREXIA (Had fever of 100.2°F), HEADACHE (Strong headache) and CHILLS (Chills). On 22-Feb-2021, PAIN (Body aches), MIGRAINE (Migraine), PYREXIA (Had fever of 100.2°F), HEADACHE (Strong headache) and CHILLS (Chills) had resolved. On 23-Feb-2021, PAIN IN EXTREMITY (Their arm felt heavy/Arm ache) had resolved.            Concomitant product use was unknown by the reporter. Treatment information was not provided.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administered a dose from a vial that had expired; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered a dose from a vial that had expired) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered a dose from a vial that had expired). On 16-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Administered a dose from a vial that had expired) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported No treatment medications were reported.  It was reported that that there was no expiration date on vial but reporter assumed that it was 15-Oct-2021.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Alopecia, Anti-thyroid antibody, Anti-thyroid antibody positive, Arthralgia, Asthenia
Clinical narrative: SCALP HAIR BECAME DRY, THIN, AND BRITTLE; SCALP HAIR BECAME DRY, THIN, AND BRITTLE; DIFFUSE SHEDDING OF SCALP HAIR; HEART PALPITATIONS; HOT FLASHES; INSOMNIA; FATIGUE AND WEAKNESS; FATIGUE AND WEAKNESS; CHEST PAIN; DIFFICULTY TAKING A DEEP BREATH; MOOD SWINGS; DIFFICULTY CONCENTRATING AND MEMORY LAPSES; DIFFICULTY CONCENTRATING AND MEMORY LAPSES; ACHING AND STIFFNESS IN KNEES, THIGHS, HIPS, AND LOWER BACK; ACHING AND STIFFNESS IN KNEES, THIGHS, HIPS, AND LOWER BACK; HAIR LOSS ON FOREARMS, EDGE OF EYEBROWS, AND LOWER LEGS/ DIFFUSE SHEDDING OF SCALP HAIR; HEAT INTOLERANCE; ELEVATED THYROID PEROXIDASE ANTIBODIES; GOITER / THYROIDITIS; GOITER / THYROIDITIS; NECK TENDERNESS IN THE AREA AROUND ADAM'S APPLE; This is a spontaneous report from a contactable consumer or other health care professional. A 46-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), (Lot Number: EWO173, Expiry date not reported) via unspecified route of administration administered in left arm on 01May2021 at 15:30 (at age of 46-years-old) as DOSE 2, SINGLE for covid-19 immunisation. Patient medical history and concomitant medications were not reported. Patient did not receive any other vaccine within four weeks. Patient received other medications in two weeks include dietary supplements. Patient previously took beta lactam antibiotics, azithromycin, ibuprofen, and experienced allergies. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 post vaccination. Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EWO150, Expiry date not reported) via unspecified route of administration, administered in left arm on 10Apr2021 at 15:30 (at age of 46-years-old) as single dose for COVID-19 Immunisation. On unspecified date in May2021 (after vaccination) patient experienced scalp hair became dry, thin and brittle, diffuse shedding of scalp hair, heart palpitations, hot flashes, insomnia, fatigue ,weakness, chest pain, difficulty taking a deep breath, mood swings, difficulty concentrating and memory lapses, aching and stiffness in knees, thighs, hips, and lower back, hair loss on forearms, edge of eyebrows, and lower legs, heat intolerance, elevated thyroid peroxidase antibodies, goiter / thyroiditis, neck tenderness in the area around adams apple. Patient did not receive treatment for the events. Adverse events resulted in doctor or other healthcare professional office/clinic visit. The Patient underwent lab test and procedures include PCR test was negative on 29Jun2021; Anti-thyroid antibody test result was elevated thyroid peroxidase antibodies on unspecified date in May 2021. The Outcome of the events was not recovered.   Follow-Up (06Sep2021): Follow-up attempts are completed. No further information is expected.   Follow-Up (07Sep2021): Follow-up attempts are completed. No further information is expected.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Disturbance in attention, Dry skin, Dyspnoea, Fatigue
Clinical narrative: SCALP HAIR BECAME DRY, THIN, AND BRITTLE; SCALP HAIR BECAME DRY, THIN, AND BRITTLE; DIFFUSE SHEDDING OF SCALP HAIR; HEART PALPITATIONS; HOT FLASHES; INSOMNIA; FATIGUE AND WEAKNESS; FATIGUE AND WEAKNESS; CHEST PAIN; DIFFICULTY TAKING A DEEP BREATH; MOOD SWINGS; DIFFICULTY CONCENTRATING AND MEMORY LAPSES; DIFFICULTY CONCENTRATING AND MEMORY LAPSES; ACHING AND STIFFNESS IN KNEES, THIGHS, HIPS, AND LOWER BACK; ACHING AND STIFFNESS IN KNEES, THIGHS, HIPS, AND LOWER BACK; HAIR LOSS ON FOREARMS, EDGE OF EYEBROWS, AND LOWER LEGS/ DIFFUSE SHEDDING OF SCALP HAIR; HEAT INTOLERANCE; ELEVATED THYROID PEROXIDASE ANTIBODIES; GOITER / THYROIDITIS; GOITER / THYROIDITIS; NECK TENDERNESS IN THE AREA AROUND ADAM'S APPLE; This is a spontaneous report from a contactable consumer or other health care professional. A 46-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), (Lot Number: EWO173, Expiry date not reported) via unspecified route of administration administered in left arm on 01May2021 at 15:30 (at age of 46-years-old) as DOSE 2, SINGLE for covid-19 immunisation. Patient medical history and concomitant medications were not reported. Patient did not receive any other vaccine within four weeks. Patient received other medications in two weeks include dietary supplements. Patient previously took beta lactam antibiotics, azithromycin, ibuprofen, and experienced allergies. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 post vaccination. Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EWO150, Expiry date not reported) via unspecified route of administration, administered in left arm on 10Apr2021 at 15:30 (at age of 46-years-old) as single dose for COVID-19 Immunisation. On unspecified date in May2021 (after vaccination) patient experienced scalp hair became dry, thin and brittle, diffuse shedding of scalp hair, heart palpitations, hot flashes, insomnia, fatigue ,weakness, chest pain, difficulty taking a deep breath, mood swings, difficulty concentrating and memory lapses, aching and stiffness in knees, thighs, hips, and lower back, hair loss on forearms, edge of eyebrows, and lower legs, heat intolerance, elevated thyroid peroxidase antibodies, goiter / thyroiditis, neck tenderness in the area around adams apple. Patient did not receive treatment for the events. Adverse events resulted in doctor or other healthcare professional office/clinic visit. The Patient underwent lab test and procedures include PCR test was negative on 29Jun2021; Anti-thyroid antibody test result was elevated thyroid peroxidase antibodies on unspecified date in May 2021. The Outcome of the events was not recovered.   Follow-Up (06Sep2021): Follow-up attempts are completed. No further information is expected.   Follow-Up (07Sep2021): Follow-up attempts are completed. No further information is expected.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Goitre, Hot flush, Insomnia, Memory impairment, Mood swings
Clinical narrative: SCALP HAIR BECAME DRY, THIN, AND BRITTLE; SCALP HAIR BECAME DRY, THIN, AND BRITTLE; DIFFUSE SHEDDING OF SCALP HAIR; HEART PALPITATIONS; HOT FLASHES; INSOMNIA; FATIGUE AND WEAKNESS; FATIGUE AND WEAKNESS; CHEST PAIN; DIFFICULTY TAKING A DEEP BREATH; MOOD SWINGS; DIFFICULTY CONCENTRATING AND MEMORY LAPSES; DIFFICULTY CONCENTRATING AND MEMORY LAPSES; ACHING AND STIFFNESS IN KNEES, THIGHS, HIPS, AND LOWER BACK; ACHING AND STIFFNESS IN KNEES, THIGHS, HIPS, AND LOWER BACK; HAIR LOSS ON FOREARMS, EDGE OF EYEBROWS, AND LOWER LEGS/ DIFFUSE SHEDDING OF SCALP HAIR; HEAT INTOLERANCE; ELEVATED THYROID PEROXIDASE ANTIBODIES; GOITER / THYROIDITIS; GOITER / THYROIDITIS; NECK TENDERNESS IN THE AREA AROUND ADAM'S APPLE; This is a spontaneous report from a contactable consumer or other health care professional. A 46-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), (Lot Number: EWO173, Expiry date not reported) via unspecified route of administration administered in left arm on 01May2021 at 15:30 (at age of 46-years-old) as DOSE 2, SINGLE for covid-19 immunisation. Patient medical history and concomitant medications were not reported. Patient did not receive any other vaccine within four weeks. Patient received other medications in two weeks include dietary supplements. Patient previously took beta lactam antibiotics, azithromycin, ibuprofen, and experienced allergies. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 post vaccination. Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EWO150, Expiry date not reported) via unspecified route of administration, administered in left arm on 10Apr2021 at 15:30 (at age of 46-years-old) as single dose for COVID-19 Immunisation. On unspecified date in May2021 (after vaccination) patient experienced scalp hair became dry, thin and brittle, diffuse shedding of scalp hair, heart palpitations, hot flashes, insomnia, fatigue ,weakness, chest pain, difficulty taking a deep breath, mood swings, difficulty concentrating and memory lapses, aching and stiffness in knees, thighs, hips, and lower back, hair loss on forearms, edge of eyebrows, and lower legs, heat intolerance, elevated thyroid peroxidase antibodies, goiter / thyroiditis, neck tenderness in the area around adams apple. Patient did not receive treatment for the events. Adverse events resulted in doctor or other healthcare professional office/clinic visit. The Patient underwent lab test and procedures include PCR test was negative on 29Jun2021; Anti-thyroid antibody test result was elevated thyroid peroxidase antibodies on unspecified date in May 2021. The Outcome of the events was not recovered.   Follow-Up (06Sep2021): Follow-up attempts are completed. No further information is expected.   Follow-Up (07Sep2021): Follow-up attempts are completed. No further information is expected.